Skip to main content
. 2018 Sep 10;15:62. doi: 10.1186/s12977-018-0444-z

Table 2.

Gag mutations with significant frequency changes across VE and VL and their associated epitopes

Patient Mutation Frequency (%) Epitope
VE VL HLA Position Sequence Location
EC02 A83S 0.0 22.9 B52 Gag (74–82) ELRSLYNTV A
S278C 0.0 22.8 B52 Gag (275–282) RMYSPTSI I
EC11 K26R 0.0 94.1 B81 Gag (19–27) IRLRPGGKK I
EC42 E40Q Ea 17.7 B51 Gag (36–44) WASRELERF I
N126S Sa 79.9 B15 Gag (127–135) QVSQNYPIV A
N126R Sa 21.0 B15 Gag (127–135) QVSQNYPIV A
EC18 K28Q 33.9 0.0 B07 Gag (22–30) RPGGKKHYM I
K28R 65.9 99.6 B07 Gag (22–30) RPGGKKHYM I
I34L 21.0 99.8 B52 Gag (34–44) LVWASRELERF I
R39K 0.0 99.5 B52 Gag (34–44) LVWASRELERF I
R43Q 17.2 0.0 B52 Gag (34–44) LVWASRELERF I
R76K 20.2 0.0 B07 Gag (71–79) GSEELRSLY I
T280A 79.7 0.0 B07/B52 Gag (274–282)/Gag (275–282) VRMYSPVSI/RMYSPTSI I
T280V 19.9 0.0 B07/B52 Gag (274–282)/Gag (275–282) VRMYSPVSI/RMYSPTSI I
T280S 0.0 99.7 B07/B52 Gag (274–282)/Gag (275–282) VRMYSPVSI/RMYSPTSI I
VC10 N126S 0.7 94.2 B15 Gag (127–135) QVSQNYPIV A
N126S 0.0 5.6 B15 Gag (127–135) QVSQNYPIV A
A146P 39.9 37.6 B15 Gag (144–152)/Gag (147–155) HQAISPRTL/ISPRTLNAW I
A146S 59.3 62.4 B15 Gag (144–152)/Gag (147–155) HQAISPRTL/ISPRTLNAW I
S173T 43.1 67.5 B15 Gag (168–175) VIPMFSAL I
I223V 41.6 32.4 B15 Gag (226–236) GQMREPRGSDI A
T280S 45.3 66.7 B15/B52 Gag (274–282)/Gag (275–282) VRMYSPTSI/RMYSPTSI I
T280I 52.7 17.4 B15/B52 Gag (274–282)/Gag (275–282) VRMYSPTSI/RMYSPTSI I
VC14 V82I 99.7 77.9 B44 Gag (78–86) LYNTVATLY I
C87Y 97.4 99.7 B44 Gag (78–86) LYNTVATLY A
I147L 99.7 81.1 B42 Gag (144–152) HQAISPRTL I
S310T 99.7 81.1 B44 Gag (306–316) AEQASQDVKNW I
VC15 V82I 43.4 84.9 B57 Gag (76–86) RSLYNTVATLY I
D121A 30.6 81.8 B57 Gag (114–122) KTQQAAADK I
T122A 49.2 82.1 B57 Gag (114–122) KTQQAAADK I
H124N 59.7 0.0 B57 Gag (114–122) KTQQAAADK A
N271T 0.0 24.7 B57 Gag (274–282) VRMYSPVSI A
T280V 1.8 98.8 B57 Gag (274–282) VRMYSPVSI I
VC16 I34L 32.2 0.0 B57 Gag (34–44) LVWASRELERF I
V35I 32.6 0.0 B57 Gag (34–44) LVWASRELERF I
V46I 29.3 0.0 B57 Gag (34–44) LVWASRELERF A
V82L 25.9 0.0 B57 Gag (76–86) RSLYNTVATLY I
A118P 24.9 0.0 B57 Gag (114–122) KTQQAAADK I
A119T 24.9 0.0 B57 Gag (114–122) KTQQAAADK I
T122A 4.8 71.6 B57 Gag (114–122) KTQQAAADK I
G123K 24.7 0.0 B57 Gag (114–122) KTQQAAADK A
H124N 99.1 64.4 B57/B14 Gag (114–122)/Gag (127–135) KTQQAAADK/QVSQNYPIV A
H124S 0.7 35.3 B57/B14 Gag (114–122)/Gag (127–135) KTQQAAADK/QVSQNYPIV A
S125R 30.9 0.0 B57/B14 Gag (114–122)/Gag (127–135) KTQQAAADK/QVSQNYPIV A
Q127H 76.7 98.3 B14 Gag (127–135) QVSQNYPIV I
I138L 75.5 94.1 B14 Gag (127–135) QVSQNYPIV A
A146P 74.6 99.4 B57 Gag (145–155) QAISPRTLNAW I
A163G 78.3 75.4 B14/B57 Gag (160–168)/Gag (162–172) EEKAFSPEV/KAFSPEVIPMF I
S165N 77.6 75.0 B14/B57 Gag (160–168)/Gag (162–172) EEKAFSPEV/KAFSPEVIPMF I
V168T 0.0 22.8 B14/B57 Gag (160–168)/Gag (162–172) EEKAFSPEV/KAFSPEVIPMF I
S173T 37.7 74.1 B57 Gag (162–172) KAFSPEVIPMF A
V191I 33.3 99.4 B14 Gag (183–191) DLNMMLNIV I
T242N 78.4 99.5 B57 Gag (240–249) TSTLQEQIGW I
D295N 0.0 9.9 B14 Gag (298–306) DRFFKTLRA A
K335R 49.2 58.9 B14 Gag (329–337) DCKTILKAL I
A340G 70.9 96.6 B14 Gag (329–337) DCKTILKAL A

aConsensus amino acid from the available bulk sequence shown instead of frequency; Location A—adjacent to epitope; Location I—within epitope